Next Article in Journal
The Compound (E)-2-Cyano-N,3-diphenylacrylamide (JMPR-01): A Potential Drug for Treatment of Inflammatory Diseases
Previous Article in Journal
Receptor Specificity Engineering of TNF Superfamily Ligands
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(1), 186; https://doi.org/10.3390/pharmaceutics14010186
Action Date Notes Link
article pdf uploaded. 13 January 2022 14:08 CET Version of Record https://www.mdpi.com/1999-4923/14/1/186/pdf-vor
article xml file uploaded 14 January 2022 07:18 CET Original file -
article xml uploaded. 14 January 2022 07:18 CET Update https://www.mdpi.com/1999-4923/14/1/186/xml
article pdf uploaded. 14 January 2022 07:18 CET Updated version of record https://www.mdpi.com/1999-4923/14/1/186/pdf
article html file updated 14 January 2022 07:20 CET Original file -
article html file updated 31 July 2022 03:39 CEST Update https://www.mdpi.com/1999-4923/14/1/186/html
Back to TopTop